Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Indian J Tuberc ; 64(4): 302-308, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28941853

ABSTRACT

BACKGROUND: As there are no data available regarding the strains of Mycobacterium tuberculosis circulating in Kashmir Valley, India, the current study aimed at describing the genetic diversity of M. tuberculosis strains in this region, by spoligotyping and 12-locus-based MIRU-VNTR typing (Mycobacterial Interspersed Repetitive Unit-Variable Number Tandem Repeat). METHODS: Sputa from 207 smear positive cases with newly diagnosed pulmonary tuberculosis were subjected to culture for M. tuberculosis. Eighty-five isolates confirmed as M. tuberculosis were subjected to drug susceptibility testing and molecular typing by spoligotyping and MIRU-VNTRs. RESULTS: Drug susceptibility results of 72 isolates revealed 76.3% as fully sensitive while 5.5% as multidrug resistant (MDR). Spoligotyping of 85 isolates detected 42 spoligotypes with 50 isolates (58.8%) clustered into seven spoligotypes. SIT26/CAS1_Del was the major spoligotype (23, 27%) followed by SIT127/H4 (12, 14.1%); CAS lineage (37.6%) was predominant, followed by Haarlem (25.8%) and ill-defined T clade (23.5%). MIRU-VNTR analysis displayed 82 MIRU patterns from 85 strains, including 3 small clusters and 79 unique. MIRU 26 was found to be the most discriminatory locus. CONCLUSIONS: Kashmir Valley has CAS as the predominant lineage of M. tuberculosis similar to the rest of the Indian sub-continent, while it is peculiar in having Euro American lineages such as Haarlem and ill-defined T clade.


Subject(s)
Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/isolation & purification , Tuberculosis, Pulmonary/microbiology , Bacterial Typing Techniques , Humans , India , Microbial Sensitivity Tests , Minisatellite Repeats , Multilocus Sequence Typing , Phylogeography , Polymerase Chain Reaction
2.
Indian J Med Microbiol ; 29(1): 60-2, 2011.
Article in English | MEDLINE | ID: mdl-21304198

ABSTRACT

Linezolid, a viable alternative to vancomycin against methicillin resistant staphylococcal isolates, has been in use for a decade around the globe. However, resistance against staphylococci remains extremely rare and unreported from most of the Asian countries. Herein, we report two cases of linezolid resistant, coagulase negative staphylococcal sepsis for the first time from India. The first case was an 18-year-old burn patient, who, after a major graft surgery, landed in sepsis, and linezolid resistant Staphylococcus cohnii with an minimum inhibitory concentration (MIC) of >256 µg/ml by both broth microdilution and Etest, was isolated from multiple blood cultures. The second patient was a 60-year-old male with an intracranial bleed and sepsis, from whose blood cultures, linezolid resistant Staphylococcus kloosii was repeatedly isolated. Linezolid MIC was >32 µg/ml by broth microdilution and >16 µg/ml by Etest.


Subject(s)
Acetamides/pharmacology , Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Oxazolidinones/pharmacology , Sepsis/microbiology , Staphylococcal Infections/microbiology , Staphylococcus/classification , Staphylococcus/drug effects , Adolescent , Coagulase/metabolism , Female , Humans , India , Linezolid , Male , Microbial Sensitivity Tests , Middle Aged , Staphylococcus/isolation & purification
3.
Indian J Med Microbiol ; 28(2): 169-71, 2010.
Article in English | MEDLINE | ID: mdl-20404469

ABSTRACT

Invasive listeriosis predominantly affects pregnant women, neonates, elderly and people with a compromised immune function. For more than 80 years since the discovery of Listeria in 1924, only a few reports of invasive listeriosis in humans have emerged from India, with all of them in patients having an underlying predisposition. We, however, report Listeria monocytogenes meningoencephalitis in an immunocompetent, previously healthy, 20-month-old female child with no underlying predisposition. The patient showed poor response to empirical treatment with vancomycin and ceftriaxone but improved dramatically after substitution with ampicillin and amikacin. She had a complete recovery other than left lateral rectus palsy that persisted.


Subject(s)
Listeria monocytogenes/isolation & purification , Meningitis, Listeria/diagnosis , Anti-Bacterial Agents/therapeutic use , Female , Humans , India , Infant , Meningitis, Listeria/complications , Meningitis, Listeria/drug therapy , Meningitis, Listeria/microbiology , Paralysis , Treatment Outcome
4.
Indian J Pathol Microbiol ; 47(1): 76-7, 2004 Jan.
Article in English | MEDLINE | ID: mdl-15471142

ABSTRACT

Endocarditis is a rare complication of typhoid fever. We report a case in which Salmonella enterica serotype typhi was isolated from a case of endocarditis. The isolate was resistant to ampicillin, chloramphenicol and ciprofloxacin but sensitive to ceftriaxone, amikacin and gentamicin.


Subject(s)
Endocarditis, Bacterial/diagnosis , Salmonella Infections/diagnosis , Salmonella typhi , Anti-Bacterial Agents , Drug Therapy, Combination/therapeutic use , Endocarditis, Bacterial/drug therapy , Endocarditis, Bacterial/microbiology , Female , Humans , Middle Aged , Salmonella Infections/drug therapy , Salmonella Infections/microbiology
5.
Indian J Med Microbiol ; 21(3): 196-8, 2003.
Article in English | MEDLINE | ID: mdl-17643019

ABSTRACT

One hundred and twenty methicillin resistant Staphylococcus aureus (MRSA) strains were checked for minimum inhibitory concenteration (MIC) of vancomycin. The results showed that 98 strains (81.7 %) had MIC < 4microg/mL, 18 strains (15 %) had MIC 8 microg/mL, and 4 (03.3%) had MIC 16 microg/mL which being borderline between sensitive (< 4microg/mL) and resistant (>32 microg/mL) values points towards possible emergence of low level vancomycin resistance in the organisms and may explain the reasons of delayed therapeutic success of vancomycin in S. aureus bacteraemia in some situations.

SELECTION OF CITATIONS
SEARCH DETAIL
...